Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1994-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.79.4.7962276PMID 7962276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

  1994cited by this paper
• Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men.

  1994cited by this paper
• Insulin and Adrenal Androgens

  1994cited by this paper
• The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families.

  1993cited by this paper
• Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.

  1993cited by this paper
• The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men.

  1993cited by this paper
• Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men.

  1992cited by this paper
• Insulin inhibits adrenal 17,20-lyase activity in man.

  1992cited by this paper
• Lower Endogenous Androgen Levels and Dyslipidemia in Men with Non-Insulin-Dependent Diabetes Mellitus

  1992cited by this paper
• Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women.

  1991cited by this paper
• Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease.

  1991cited by this paper
• Suppression of circulating delta 4-androstenedione and dehydroepiandrosterone sulfate during oral glucose tolerance test in normal females.

  1991cited by this paper
• Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women.

  1991cited by this paper
• Clinical review 26: Insulin resistance in obese and nonobese man.

  1991cited by this paper
• Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index.

  1991cited by this paper
• A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

  1991cited by this paper
• Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women.

  1990cited by this paper
• Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

  1990cited by this paper
• Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

  1989cited by this paper
• Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.

  1989cited by this paper
• Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms.

  1989cited by this paper
• Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.

  1989cited by this paper
• Adrenal Androgens in Clinical Medicine

  1989cited by this paper
• Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex.

  1988cited by this paper
• Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding.

  1988cited by this paper
• Androgen and insulin response to an oral glucose challenge in hyperandrogenic women.

  1987cited by this paper
• Maintenance of Normal Circulating Levels of Δ4-Androstenedione and Dehydroepiandrosterone in Simple Obesity Despite Increased Metabolic Clearance Rates: Evidence for a Servo-Control Mechanism*

  1987cited by this paper
• The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.

  1987cited by this paper
• Maintenance of normal circulating levels of delta 4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: evidence for a servo-control mechanism.

  1987cited by this paper
• Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride.

  1985cited by this paper
• Adrenal androgen concentrations in endometrium and plasma during the menstrual cycle.

  1984cited by this paper
• Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.

  1984cited by this paper
• Plasma androgens and menstrual cycle: physiopathological correlates from adolescence to menopause.

  1983cited by this paper
• Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels.

  1982cited by this paper
• Sex difference in the metabolism of dehydroisoandrosterone sulfate.

  1980cited by this paper
• Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults.

  1980cited by this paper
• 24-Hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate.

  1975cited by this paper
• The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man.

  1973cited by this paper
• Further evidence of altered adrenocortical function in hypertension. Dehydroepiandrosterone excretion rate.

  1968cited by this paper
• A possible interrelation between glucose-6-phosphate dehydrogenase and dehydroepiandrosterone in obesity.

  1967cited by this paper

• Cellular Senescence in Adrenocortical Biology and Its Disorders

  2021cites this paper
• Altered metabolic homeostasis is associated with appetite regulation during and following 48-h of severe energy deprivation in adults.

  2016cites this paper
• Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

  2012cites this paper
• Appetite and Endocrine Regulators of Energy Balance After 2 Days of Energy Restriction: Insulin, Leptin, Ghrelin, and DHEA‐S

  2011cites this paper
• Comparative Study of Serum Dehydroepiandrosterone Sulfate Levels in HIV-1 Infected and HIV-1-seronegative Royal Thai Army Conscripts

  2010cites this paper
• Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes

  2008cites this paper
• INFLUENCE OF LISINOPRIL ON GLUCOSE LOWERING EFFECT OF GLIPIZIDE IN NORMAL AND DIABETIC RATS

  2008cites this paper
• INFLUENCE OF BENAZEPRIL ON GLUCOSE LOWERING EFFECT OF GLIPIZIDE IN NORMAL AND DIABETIC RATS

  2007cites this paper
• Consensus Document on substitution therapy with DHEA in the elderly

  2006cites this paper
• Insulin resistance and the polycystic ovary syndrome

  2005cites this paper
• Antihypertensive drugs and insulin resistance in obesity.

  2005cites this paper
• Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.

  2004cites this paper
• The androgenic profile of women with non-insulin-dependent diabetes mellitus.

  2004cites this paper
• DHEAS as a new diagnostic tool.

  2004cites this paper
• Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.

  2003cites this paper
• The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies

  2002cites this paper
• Adrenal androgens in the polycystic ovary syndrome

  2002cites this paper
• Potential Therapeutic Effects of Prescribed and Over-the-Counter Androgens in Women

  2001cites this paper
• Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates.

  2001cites this paper
• Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome

  2001cites this paper
• Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.

  2001cites this paper
• Do DHEA/DHEAS play a protective role in coronary heart disease?

  2000cites this paper
• A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension.

  1999cites this paper
• Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels

  1999cites this paper
• Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies

  1999cites this paper
• DHEA and DHEA‐S: A Review

  1999cites this paper
• Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome.

  1999cites this paper
• Activation of 11 beta-hydroxysteroid dehydrogenase by dehydroepiandrosterone sulphate as an anti-hypertensive agent in spontaneously hypertensive rats.

  1998cites this paper
• Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome

  1998cites this paper
• Dehydroepiandrosterone (DHEA) and DHEA-Sulfate (DS) as Therapeutic Options in Menopause

  1998cites this paper
• Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts.

  1998cites this paper
• Phenotype and genotype in polycystic ovary syndrome.

  1998cites this paper
• Nutritional and endocine modulation of intracellular calcium: Implications in obesity, insulin resistance and hypertension

  1998cites this paper
• Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study.

  1998cites this paper
• Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

  1998cites this paper
• Drug Metabolism: Activation of 11 β‐Hydroxysteroid Dehydrogenase by Dehydroepiandrosterone Sulphate as an Anti‐hypertensive Agent in Spontaneously Hypertensive Rats

  1998cites this paper
• Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?

  1997cites this paper
• Dehydroepiandrosterone (DHEA) and aging.

  1997cites this paper
• Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications

  1997cites this paper
• Relations between fasting serum insulin, glucose, and dihydroepiandrosterone-sulfate concentrations in obese patients with hypertension: short-term effects of antihypertensive drugs.

  1997cites this paper
• Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis.

  1997cites this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cites this paper
• The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

  1996cites this paper
• DHEA: a hormone with multiple effects.

  1996cites this paper
• Antidiabetic characteristics of dehydroepiandrosterone in animal and human studies

  1996cites this paper
• The effects of calcium channel blockade on agouti‐induced obesity

  1996cites this paper
• Dehydroepiandrosterone sulfate inhibition of catecholamine secretion from bovine adrenal chromaffin cells.

  1996cites this paper
• Adrenocortical Dysfunction in the Polycystic Ovary Syndrome

  1996cites this paper
• Insulin Resistance in the Polycystic Ovary Syndrome

  1996cites this paper
• Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women.

  1995cites this paper
• Nitrendipine treatment in women with polycystic ovarian syndrome: evidence for a lack of effects of calcium channel blockers on insulin, androgens, and sex hormone-binding globulin.

  1995cites this paper
• Dehydroepiandrosterone Sulfate and Aging

  1995cites this paper
• Obesity and dehydroepiandrosterone/dehydroepiandrosterone sulfate relationships in lean, obese, and meat-type cross-bred boars: responses to porcine growth hormone.

  1995cites this paper
• Regulation of Human Dehydroepiandrosterone Metabolism by Insulin a

  1995cites this paper
• Are There Sex-Specific Effects of Insulin on Human Dehydroepiandrosterone Metabolism?

  1995cites this paper
• Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men.

  1995cites this paper